LoGiudice John A, Adamson Karri, Ghanayem Nancy, Woods Ronald K, Mitchell Michael E
Department of Plastic Surgery, Medical College of Wisconsin, 1155 N. Mayfair Road, Milwaukee, WI 53226, USA.
Department of Plastic Surgery, Medical College of Wisconsin, 1155 N. Mayfair Road, Milwaukee, WI 53226, USA.
J Plast Reconstr Aesthet Surg. 2017 May;70(5):639-645. doi: 10.1016/j.bjps.2017.02.002. Epub 2017 Feb 17.
Pediatric congenital heart disease patients are at risk for vascular injuries during surgical procedures or when the arterial system is accessed for monitoring or diagnostic studies. Our treatment of emergent situations in this patient population using microvascular techniques shows the feasibility of such techniques.
A retrospective chart review of patients aged 0-18 years with congenital heart disease identified six patients who underwent microvascular surgery by the senior surgeon from June 2007 to May 2015. We studied this series, highlighting technical aspects of surgery and perioperative care to determine their effect on outcome.
Six patients with congenital cardiac defects requiring cardiothoracic surgery were studied, body weight ranging from 3.2 to 19.1 kg at the time of surgery. Five suffered iatrogenic arterial injury to the heart or vessels used for access or diagnostic studies, including coronary artery laceration, brachial artery thrombosis, and external iliac artery avulsion. Interventions included direct end-to-end repair and vein grafting. Vessel diameter averaged 1 mm. Patients received vasopressors intraoperatively and were on vasopressors and antihypertensives postoperatively. One patient died because of disseminated intravascular coagulation on postoperative day 17, but bypass graft was patent prior to death. The rest survived with clinical evidence of patency of the repaired vessel for a long-term.
Microsurgical intervention may be life-saving as a revascularization procedure to the heart by direct coronary repair or bypass grafting. Iatrogenic injuries to the limb may cause critical ischemia; limbs can be salvaged by microsurgical repair. Despite technical and physiological challenges, microsurgery is feasible and sometimes crucial in this patient population.
小儿先天性心脏病患者在外科手术期间或在为监测或诊断研究而接入动脉系统时存在血管损伤风险。我们使用微血管技术治疗该患者群体中的紧急情况,显示了此类技术的可行性。
对年龄在0至18岁的先天性心脏病患者进行回顾性病历审查,确定了2007年6月至2015年5月期间由资深外科医生进行微血管手术的6例患者。我们研究了该系列病例,重点关注手术技术方面和围手术期护理,以确定它们对治疗结果的影响。
研究了6例需要心胸外科手术的先天性心脏缺陷患者,手术时体重在3.2至19.1千克之间。5例患者在用于接入或诊断研究的心脏或血管处发生医源性动脉损伤,包括冠状动脉撕裂、肱动脉血栓形成和髂外动脉撕裂。干预措施包括直接端端修复和静脉移植。血管直径平均为1毫米。患者术中接受血管升压药治疗,术后使用血管升压药和抗高血压药。1例患者在术后第17天因弥散性血管内凝血死亡,但旁路移植血管在死亡前保持通畅。其余患者存活,修复血管长期通畅的临床证据显示良好。
微血管手术干预作为一种通过直接冠状动脉修复或旁路移植进行心脏血运重建的手术可能挽救生命。肢体的医源性损伤可能导致严重缺血;微血管修复可挽救肢体。尽管存在技术和生理挑战,但微血管手术在该患者群体中是可行的,有时甚至至关重要。